These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 21532237)

  • 1. A case of acquired Fanconi syndrome induced by zoledronic acid.
    Yoshinami T; Yagi T; Sakai D; Sugimoto N; Imamura F
    Intern Med; 2011; 50(9):1075-9. PubMed ID: 21532237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A Case of Fanconi Syndrome Induced by Zoledronic Acid in a Metastatic Colorectal Cancer Patient].
    Okagawa Y; Sato Y; Onuma H; Osuga T; Hayashi T; Sato T; Miyanishi K; Kobune M; Takimoto R; Kato J
    Gan To Kagaku Ryoho; 2015 Jul; 42(7):867-70. PubMed ID: 26197752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of zoledronate-induced tubulointerstitial nephritis with Fanconi syndrome.
    Torimoto K; Okada Y; Arao T; Mori H; Tanaka Y
    Endocr J; 2012; 59(12):1051-6. PubMed ID: 22814143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zoledronic acid-associated symmetrical drug-related intertriginous and flexural exanthema (SDRIFE): report of baboon syndrome in a woman with recurrent metastatic breast cancer after receiving zoledronic acid.
    Cohen PR
    Dermatol Online J; 2015 Aug; 21(8):. PubMed ID: 26437156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential effect of zoledronate therapy in heavy proteinuria.
    Gokden N; Zangari M; Elici F; Barlogie B; Kumar J
    Clin Nephrol; 2007 Apr; 67(4):263-5. PubMed ID: 17474565
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical study of zoledronic acid in the treatment of cancer-induced hypercalcemia].
    Shen G; Song ST; Jiang ZF; Bian SG; Xie GR; Wang YJ; Wang JJ
    Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):632-4. PubMed ID: 16438878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subtrochanteric fracture in a patient receiving zoledronic acid therapy for metastatic breast cancer.
    Kishimoto Y; Iwase T; Koyama A; Masui T; Yoshida G; Matsuo H; Ishiguro N
    Nagoya J Med Sci; 2011 Aug; 73(3-4):211-5. PubMed ID: 21928703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anterior uveitis complicating zoledronic acid infusion.
    Colucci A; Modorati G; Miserocchi E; Di Matteo F; Rama P
    Ocul Immunol Inflamm; 2009; 17(4):267-8. PubMed ID: 19657981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zoledronic acid induced osteonecrosis of tibia and femur.
    Gupta S; Jain P; Kumar P; Parikh PM
    Indian J Cancer; 2009; 46(3):249-50. PubMed ID: 19574685
    [No Abstract]   [Full Text] [Related]  

  • 10. [Preclinical and clinical profile of zoledronic acid (Zometa) for hypercalcemia of malignancy].
    Tomoo T; Suzuki M
    Nihon Yakurigaku Zasshi; 2005 Nov; 126(5):353-7. PubMed ID: 16394581
    [No Abstract]   [Full Text] [Related]  

  • 11. Fanconi Syndrome Associated with Long-term Treatment with Zoledronate.
    Katsunuma R; Mitsumoto K; Mizumoto A; Hirai Y; Nakauchi C; Uzu T
    Intern Med; 2023 Jul; 62(14):2103-2105. PubMed ID: 36450467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uveitis, a rare but important complication of adjuvant zoledronic acid for early-stage breast cancer.
    Chacko G; Kota S; Kumar S; Ohri N; Omene C; Ganesan S; Toppmeyer DL; George MA
    Anticancer Drugs; 2023 Apr; 34(4):592-594. PubMed ID: 36846985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A hitherto unreported high incidence of zoledronic acid-induced acute phase reaction in patients with cancer treatment-induced bone loss.
    Santini D; Vincenzi B; Caraglia M; Tonini G
    Ann Oncol; 2007 Jan; 18(1):201-202. PubMed ID: 17021272
    [No Abstract]   [Full Text] [Related]  

  • 14. Zoledronic Acid-Associated Fanconi Syndrome in Patients With Cancer.
    Portales-Castillo I; Mount DB; Nigwekar SU; Yu EW; Rennke HG; Gupta S
    Am J Kidney Dis; 2022 Oct; 80(4):555-559. PubMed ID: 35219759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zoledronic acid. A bisphosphonate for hypercalcemia of malignancy and osteolytic metastases.
    Massaro AM
    Cancer Pract; 2002; 10(4):219-21. PubMed ID: 12100107
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute unilateral anterior uveitis and scleritis following a single infusion of zoledronate for metastatic breast cancer.
    Moore MM; Beith JM
    Med J Aust; 2008 Mar; 188(6):370-1. PubMed ID: 18341464
    [No Abstract]   [Full Text] [Related]  

  • 17. Unilateral anterior uveitis complicating zoledronic acid therapy in breast cancer.
    El Saghir NS; Otrock ZK; Bleik JH
    BMC Cancer; 2005 Dec; 5():156. PubMed ID: 16332258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of zoledronic acid in patients with breast cancer metastatic to bone: a multicenter clinical trial.
    Cartenì G; Bordonaro R; Giotta F; Lorusso V; Scalone S; Vinaccia V; Rondena R; Amadori D
    Oncologist; 2006; 11(7):841-8. PubMed ID: 16880243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteonecrosis of the jaw (ONJ) risk in breast cancer patients after zoledronic acid treatment.
    Fusco V; Loidoris A; Colella G; Vescovi P; Campisi G
    Breast; 2010 Oct; 19(5):432-3; author reply 433-4. PubMed ID: 20363135
    [No Abstract]   [Full Text] [Related]  

  • 20. Severe non-infective systemic inflammatory response syndrome, shock, and end-organ dysfunction after zoledronic acid administration in a child.
    Trivedi S; Al-Nofal A; Kumar S; Tripathi S; Kahoud RJ; Tebben PJ
    Osteoporos Int; 2016 Jul; 27(7):2379-2382. PubMed ID: 26892041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.